BHP Group Ltd
BHP
Fortescue Ltd
FMG
Telstra Group Ltd
TLS
Rio Tinto Ltd
RIO
ANZ Group Holdings Ltd
ANZ
AU Stock MarketDetailed Quotes
NUZ Neurizon Therapeutics Ltd
- 0.155
- -0.005-3.13%
20min DelayTrading Feb 18 11:48 AET
76.31MMarket Cap-7.38P/E (Static)
0.160High0.155Low89.38KVolume0.160Open0.160Pre Close13.91KTurnover0.24552wk High0.03%Turnover Ratio492.31MShares0.11552wk Low-0.021EPS TTM54.40MFloat Cap0.245Historical HighLossP/E (Static)350.97MShs Float0.115Historical Low-0.021EPS LYR3.13%Amplitude--Dividend TTM7.38P/B1Lot Size--Div YieldTTM
About Neurizon Therapeutics Ltd Company
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).
Company Profile
SymbolNUZ
Company NameNeurizon Therapeutics Ltd
Founded2000
MarketASX
Employees52
Fiscal Year Ends06-30
Address96-100 Albert Road Level 4
CityMelbourne
CountryAustralia
Zip Code3205
Phone+61 396927222
Websitehttps://www.neurizon.com
Share RegistryAUTOMIC REGISTRY SERVICES
Suite 5, Level 12, 530 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
1300 288 664
Company Executives
- Name
- Position
- Salary
- Michael Thurn
- Chief Executive Officer,Managing Director
- --
- Sergio Duchini
- Non-Executive Chairman,Non-Executive Director
- --
- Marcus Hughes
- Non-Executive Director
- --
- Kathryn(Katie) MacFarlane
- Non-Executive Director
- --